High Court Rejects ‘After-Arising Technology’ Challenge To Entresto Patent
WASHINGTON, D.C. — The U.S. Supreme Court on Dec. 15 rejected a generic drugmaker’s petition for a writ of certiorari, leaving in place a Federal Circuit U.S. Court of Appeals ruling...To view the full article, register now.
Already a subscriber? Click here to view full article